328 related articles for article (PubMed ID: 9143694)
1. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
Rickinson AB; Moss DJ
Annu Rev Immunol; 1997; 15():405-31. PubMed ID: 9143694
[TBL] [Abstract][Full Text] [Related]
2. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
3. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
5. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ
J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222
[TBL] [Abstract][Full Text] [Related]
6. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.
Lee SP; Tierney RJ; Thomas WA; Brooks JM; Rickinson AB
J Immunol; 1997 Apr; 158(7):3325-34. PubMed ID: 9120290
[TBL] [Abstract][Full Text] [Related]
7. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
[TBL] [Abstract][Full Text] [Related]
8. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
[TBL] [Abstract][Full Text] [Related]
9. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
Khanna R; Burrows SR; Moss DJ; Silins SL
J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
[TBL] [Abstract][Full Text] [Related]
10. Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.
Steven NM; Leese AM; Annels NE; Lee SP; Rickinson AB
J Exp Med; 1996 Nov; 184(5):1801-13. PubMed ID: 8920868
[TBL] [Abstract][Full Text] [Related]
11. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
[TBL] [Abstract][Full Text] [Related]
12. Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition.
Lee SP; Constandinou CM; Thomas WA; Croom-Carter D; Blake NW; Murray PG; Crocker J; Rickinson AB
Blood; 1998 Aug; 92(3):1020-30. PubMed ID: 9680372
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
[TBL] [Abstract][Full Text] [Related]
15. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
[TBL] [Abstract][Full Text] [Related]
16. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus.
Campos-Lima PO; Levitsky V; Imreh MP; Gavioli R; Masucci MG
J Exp Med; 1997 Jul; 186(1):83-9. PubMed ID: 9207000
[TBL] [Abstract][Full Text] [Related]
17. Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.
Kimura H; Tsuge I; Imai S; Yamamoto M; Kuzushima K; Osato T; Morishima T
Med Microbiol Immunol; 1995 Aug; 184(2):63-8. PubMed ID: 7500912
[TBL] [Abstract][Full Text] [Related]
18. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
[TBL] [Abstract][Full Text] [Related]
19. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.
Silins SL; Cross SM; Krauer KG; Moss DJ; Schmidt CW; Misko IS
J Clin Invest; 1998 Oct; 102(8):1551-8. PubMed ID: 9788968
[TBL] [Abstract][Full Text] [Related]
20. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.
Gottschalk S; Ng CY; Perez M; Smith CA; Sample C; Brenner MK; Heslop HE; Rooney CM
Blood; 2001 Feb; 97(4):835-43. PubMed ID: 11159505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
